Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

Canadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

Cardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

CIRCULATION JOURNAL, published by the Japanese Circulation Society, stands as a premier platform for cutting-edge research in the fields of Cardiology and Cardiovascular Medicine. With an impressive impact factor placing it in the Q1 quartile for both cardiology and general medicine, this journal is essential for researchers and practitioners seeking to stay at the forefront of cardiovascular science. The journal's accessible open access options ensure that groundbreaking studies are widely disseminated, reflecting its commitment to advancing medical knowledge and improving patient care. Since its inception in 1996, CIRCULATION JOURNAL has fostered a global dialogue on vital cardiovascular issues, making it a vital resource for academics, healthcare professionals, and students alike. With its base in Tokyo, Japan, the journal not only highlights regional advancements but also contributes significantly to the global medical community.

JOURNAL OF INVASIVE CARDIOLOGY, a reputable publication by H M P COMMUNICATIONS, is dedicated to advancing the field of cardiology and cardiovascular medicine through rigorous research and scholarly discussion. With an ISSN of 1042-3931 and an E-ISSN of 1557-2501, this journal serves as a crucial resource for healthcare professionals, researchers, and students who seek to stay informed about the latest findings and innovations in invasive cardiology. Having achieved a 2023 Scopus rank of #185 out of 636 in General Medicine, placing it in the 70th percentile, the journal is recognized for its significant contributions to medical science, evidenced by its Q2 ranking in Radiology, Nuclear Medicine and Imaging, and Q3 status in both Cardiology and Cardiovascular Medicine. The journal has been in circulation since 1990 and continues to foster a platform for critical research in the United States, ensuring accessibility to vital information necessary for enhancing patient care and clinical practices within the domain of invasive procedures.

EuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.